Original document(71 pages)  中文版
    The invention provides several polymorphic forms and an amorphous form of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6ylamino]-phenyl}-amide, pharmaceutical compositions containing such polymorphic or amorphous forms, and methods of using such pharmaceutical compositions to treat disease states mediated by protein kinases, such as cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation.
Application Number
申请号		 200580008283 Application Date
申请日		 2005.03.04
Title 名称 Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide
Publication Number
公开号		 1930148 Publication Date
公开日		 2007.03.14
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D401/14
Applicant(s) Name
申请人		 Pfizer
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 lijian
More information 更  多  信  息


 Related patents information
Method and device for measuring concentration of anesthetic gas
Method and system for ion beam containment in an ion beam guide
Automation purchase system for initial roasting tobacco package
Technique for two-stage controlled ecological fresh water aquiculturing Penaeus vannamei Boone
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.